Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewCell biologyInflammation Open Access | 10.1172/jci.insight.170121

An LRP1-binding motif in cellular prion protein replicates cell-signaling activities of the full-length protein

Elisabetta Mantuano,1 Carlotta Zampieri,1 Pardis Azmoon,1 Cory B. Gunner,1 Kyle R. Heye,1 and Steven L. Gonias1

1Department of Pathology, University of California San Diego, La Jolla, United States of America

Find articles by Mantuano, E. in: PubMed | Google Scholar |

1Department of Pathology, University of California San Diego, La Jolla, United States of America

Find articles by Zampieri, C. in: PubMed | Google Scholar

1Department of Pathology, University of California San Diego, La Jolla, United States of America

Find articles by Azmoon, P. in: PubMed | Google Scholar |

1Department of Pathology, University of California San Diego, La Jolla, United States of America

Find articles by Gunner, C. in: PubMed | Google Scholar

1Department of Pathology, University of California San Diego, La Jolla, United States of America

Find articles by Heye, K. in: PubMed | Google Scholar

1Department of Pathology, University of California San Diego, La Jolla, United States of America

Find articles by Gonias, S. in: PubMed | Google Scholar |

Published June 27, 2023 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.170121.
Copyright © 2023, Mantuano et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 27, 2023 - Version history
View PDF
Abstract

Low Density Lipoprotein Receptor-related Protein-1 (LRP1) functions as a receptor for non-pathogenic cellular prion protein (PrPC), which is released from cells by ADAM proteases or in extracellular vesicles. This interaction activates cell-signaling and attenuates inflammatory responses. We screened 14-mer PrPC-derived peptides and identified a putative LRP1 recognition motif in the PrPC sequence spanning residues 98-111. A synthetic peptide (P3) corresponding to this region replicated the cell-signaling and biological activities of full-length shed PrPC. P3 blocked lipopolysaccharide (LPS)-elicited cytokine expression in macrophages and microglia and rescued the heightened sensitivity to LPS in mice in which the PrPC gene (Prnp) is deleted. P3 activated ERK1/2 and induced neurite outgrowth in PC12 cells. The response to P3 required LRP1 and the NMDA Receptor and was blocked by the PrPC-specific antibody, POM2. P3 has Lys residues, which are typically necessary for LRP1-binding. Converting Lys100 and Lys103 into Ala eliminated the activity of P3, suggesting that these residues are essential in the LRP1 binding motif. A P3 derivative in which Lys105 and Lys109 were converted into Ala retained activity. We conclude that the biological activities of shed PrPC, attributed to interaction with LRP1, are retained in synthetic peptides, which may be templates for therapeutics development. 

Graphical Abstract
graphical abstract
Supplemental material

View Supplemental figure 1

Version history
  • Version 1 (June 27, 2023): In-Press Preview
  • Version 2 (August 8, 2023): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts